2021
DOI: 10.1681/asn.2020060777
|View full text |Cite
|
Sign up to set email alerts
|

Uncovering Modifier Genes of X-Linked Alport Syndrome Using a Novel Multiparent Mouse Model

Abstract: Background: Mutations in COL4A5 are responsible for 80% of cases of X-linked Alport Syndrome (XLAS). Although genes that cause AS are well characterized, people with AS who have similar genetic mutations present with a wide variation in the extent of kidney impairment and age of onset, suggesting the activities of modifier genes. Methods: We created a cohort of genetically diverse XLAS male and female mice using the Diversity Outbred mouse resource, and measured albuminuria, glomerular filtration rate (GFR), a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 27 publications
(56 reference statements)
0
18
0
Order By: Relevance
“…Other formins might be involved in other kidney disorders. For instance, Fmn1 has recently been identified as a candidate modifier gene in X-linked Alport syndrome in mice, which is a genetic disease characterized by hearing loss, hematuria and, eventually, renal failure [115].…”
Section: Monogenic Disorders Caused By Formin Mutation 21 Nephrotic Syndrome and Charcot-marie-tooth Diseasementioning
confidence: 99%
“…Other formins might be involved in other kidney disorders. For instance, Fmn1 has recently been identified as a candidate modifier gene in X-linked Alport syndrome in mice, which is a genetic disease characterized by hearing loss, hematuria and, eventually, renal failure [115].…”
Section: Monogenic Disorders Caused By Formin Mutation 21 Nephrotic Syndrome and Charcot-marie-tooth Diseasementioning
confidence: 99%
“…Notwithstanding the role of allelic heterogeneity in interpreting the clinical phenotype, the likely role of genetic modifiers has also been implicated [ 13 , 14 ]. AS mouse models are a useful tool for eliminating this genetic heterogeneity bias, helping in the study of the syndrome in a more restricted and relatively more homogeneous genomic background while, at the same time, allowing us to design experiments involving higher and controlled genetic heterogeneity [ 15 ]. It does not escape our attention that other parameters, including environmental factors (i.e., temperature, light-dark cycle, food, water, and other mouse room conditions), might contribute to the clinical heterogeneity observed between the mice.…”
Section: Alport Syndromementioning
confidence: 99%
“…In Alport syndrome, the rates of progression vary depending on the murine strains. Although Alport mice with a B6 genetic background develop progressive glomerular disease, the progression is slower than that in other strains [ 112 , 113 , 114 , 115 ]. These strain-dependent disparities strongly indicate the presence of modifier genes.…”
Section: Genetic Susceptibility To Tns2-deficient Nephropathymentioning
confidence: 99%